Compounds > catechin

catechin and Bladder Cancer

catechin has been researched along with Bladder Cancer in 26 studies

Research

Studies (26)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (3.85)18.2507
2000's10 (38.46)29.6817
2010's14 (53.85)24.3611
2020's1 (3.85)2.80

Authors

AuthorsStudies
Chang, WA; Chen, YJ; Ke, HL; Kuo, PL; Lee, HY; Li, WM; Wu, WJ1
Cai, J; Kang, L; Li, J; Li, Y; Liu, X; Luo, J; Yin, Z; Zhang, L1
Bailey, HH; Downs, T; Gee, JR; Havighurst, TC; House, MG; Huang, W; Kim, K; Kolesar, J; Mukhtar, H; Parnes, HL; Saltzstein, DR; Stublaski, J; Wollmer, BW1
Bednarski, W; Dettlaff, K; Jankun, J; Jelińska, A; Keck, RW; Khan, OA; Mostafa, IH; Ogrodowczyk, M; Stawny, M; Wątróbska-Świetlikowska, D1
Atala, A1
Geng, H; Li, E; Li, Y; Song, J; Sun, X; Yu, D; Zhong, C1
Jankun, J; Keck, RW; Selman, SH1
Chen, W; Chen, Z; Fang, Y; Guo, L; Liu, ZP; Lu, J; Luo, J; Wei, J; Yu, T; Zhou, B1
Lei, T; Wang, S; Zhang, M1
Cai, ZM; Cheng, BH; Huang, WR; Lung, WY; Luo, KW; Wei, XY1
Chancellor, MB; Coyle, CH; Morrisroe, SN; Philips, BJ; Yoshimura, N1
Keck, RW; Selman, SH1
Chen, NG; Chung, JG; Ho, YJ; Lai, CH; Lin, TH; Lin, YC; Lin, YH; Lu, CC; Shen, WC; Yang, JS1
Hsieh, DS; Huang, YH; Tan, SW; Tsai, CY; Wang, H; Wu, CJ; Yeh, MK1
Chen, SC; Chiang, CK; Chuang, YT; Huang, KH; Kuo, KL; Liu, SH; Pu, YS; Tsai, YC; Weng, TI1
Bai, Y; Kong, D; Lin, Y; Mao, Q; Qin, J; Wang, Y; Xie, L; Yang, K; Zheng, X1
Matsushima, M; Sato, D1
Gomez, MA; Hampton, JA; Keck, RW; Kemberling, JK; Selman, SH1
Facchini, A; Flamigni, F; Guarnieri, C; Stefanelli, C; Zanella, B1
Chen, JJ; Koo, MW; Ye, ZQ1
Jackson, BJ; Kandzari, S; McFadden, D; Mohseni, H; Riggs, DR; Zaslau, S1
Bode, AM; Choi, BY; Choi, HS; Dong, Z; Ermakova, SP; Kang, BS; Ma, WY; Schuster, TF1
Bai, Y; Dahiya, R; Li, LC; Qin, J; Shen, HF; Wang, YB; Xie, LP; Zheng, XY1
Bernier, T; Hanley, R; Kim, J; Le, SM; Libertino, JA; Lodowsky, C; Marie, PJ; Rieger-Christ, KM; Roth, M; Summerhayes, IC; Vemulapalli, P; Yee, AS1
Crowell, JA; Grubbs, CJ; Hara, Y; Juliana, MM; Kapetanovic, IM; Lee, MJ; Lubet, RA; Steele, VE; Yang, CS1
Sato, D1

Trials

1 trial(s) available for catechin and Bladder Cancer

ArticleYear
A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers.
    Cancer prevention research (Philadelphia, Pa.), 2017, Volume: 10, Issue:5

    Topics: Adult; Aged; Biomarkers, Tumor; Catechin; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Pilot Projects; Tissue Distribution; Urinary Bladder; Urinary Bladder Neoplasms

2017

Other Studies

25 other study(ies) available for catechin and Bladder Cancer

ArticleYear
Effects of Epigallocatechin Gallate (EGCG) on Urinary Bladder Urothelial Carcinoma-Next-Generation Sequencing and Bioinformatics Approaches.
    Medicina (Kaunas, Lithuania), 2019, Dec-01, Volume: 55, Issue:12

    Topics: Anticarcinogenic Agents; Carcinoma, Transitional Cell; Catechin; Cell Line, Tumor; Computational Biology; High-Throughput Nucleotide Sequencing; Humans; MicroRNAs; Signal Transduction; Urinary Bladder Neoplasms

2019
Epigallocatechin-3-gallate induces autophagy-related apoptosis associated with LC3B II and Beclin expression of bladder cancer cells.
    Journal of food biochemistry, 2021, Volume: 45, Issue:6

    Topics: Apoptosis; Autophagy; Beclin-1; Catechin; Cell Line, Tumor; Humans; Microtubule-Associated Proteins; Phosphatidylinositol 3-Kinases; Urinary Bladder Neoplasms

2021
Formulation and characterization of EGCG for the treatment of superficial bladder cancer.
    International journal of molecular medicine, 2017, Volume: 40, Issue:2

    Topics: Anticarcinogenic Agents; Catechin; Chromatography, High Pressure Liquid; Cold Temperature; Filtration; Freeze Drying; Humans; Radiation, Ionizing; Sterilization; Urinary Bladder Neoplasms

2017
Re: Mg(II)-Catechin Nanoparticles Delivering siRNA Targeting EIF5A2 Inhibit Bladder Cancer Cell Growth In Vitro and In Vivo.
    The Journal of urology, 2017, Volume: 198, Issue:2

    Topics: Catechin; Cell Line, Tumor; Cell Proliferation; Humans; Nanoparticles; RNA, Small Interfering; Urinary Bladder Neoplasms

2017
(‑)‑Epigallocatechin‑3‑gallate inhibits bladder cancer stem cells via suppression of sonic hedgehog pathway.
    Oncology reports, 2019, Volume: 42, Issue:1

    Topics: Biomarkers, Tumor; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Gene Expression Regulation, Neoplastic; Hedgehog Proteins; Humans; Neoplastic Stem Cells; Signal Transduction; Urinary Bladder Neoplasms

2019
Epigallocatechin-3-gallate prevents tumor cell implantation/growth in an experimental rat bladder tumor model.
    International journal of oncology, 2014, Volume: 44, Issue:1

    Topics: Animals; Catechin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Female; Humans; Mitomycin; Neoplasms, Experimental; Rats; Urinary Bladder Neoplasms

2014
Mg(II)-Catechin nanoparticles delivering siRNA targeting EIF5A2 inhibit bladder cancer cell growth in vitro and in vivo.
    Biomaterials, 2016, Volume: 81

    Topics: Animals; Antineoplastic Agents; Apoptosis; Catechin; Cell Line, Tumor; Cell Proliferation; Eukaryotic Translation Initiation Factor 5A; Female; Fluorescein; Gene Knockdown Techniques; Injections; Intracellular Space; Magnesium; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Peptide Initiation Factors; RNA-Binding Proteins; RNA, Small Interfering; Spectroscopy, Fourier Transform Infrared; Subcutaneous Tissue; Tissue Distribution; Transfection; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays

2016
The Reversal Effect and Its Mechanisms of Tetramethylpyrazine on Multidrug Resistance in Human Bladder Cancer.
    PloS one, 2016, Volume: 11, Issue:7

    Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Catechin; Cell Cycle; Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Ginsenosides; Humans; Neoplasm Proteins; Pyrazines; Urinary Bladder Neoplasms

2016
EGCG inhibited bladder cancer SW780 cell proliferation and migration both in vitro and in vivo via down-regulation of NF-κB and MMP-9.
    The Journal of nutritional biochemistry, 2017, Volume: 41

    Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Catechin; Cell Line, Tumor; Dose-Response Relationship, Drug; Down-Regulation; Female; Humans; Injections, Intraperitoneal; Matrix Metalloproteinase 9; Mice, Inbred BALB C; Mice, Nude; Neoplasm Invasiveness; Neoplasm Proteins; NF-kappa B; Random Allocation; Specific Pathogen-Free Organisms; Tumor Burden; Urinary Bladder; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays

2017
Induction of apoptosis in human bladder cancer cells by green tea catechins.
    Biomedical research (Tokyo, Japan), 2009, Volume: 30, Issue:4

    Topics: Apoptosis; Catechin; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Oligonucleotide Array Sequence Analysis; Plant Extracts; Signal Transduction; Tea; Urinary Bladder Neoplasms

2009
A comparative study of the inhibiting effects of mitomycin C and polyphenolic catechins on tumor cell implantation/growth in a rat bladder tumor model.
    The Journal of urology, 2011, Volume: 186, Issue:2

    Topics: Animals; Antibiotics, Antineoplastic; Anticarcinogenic Agents; Catechin; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Drug Screening Assays, Antitumor; Female; Mitomycin; Rats; Rats, Inbred F344; Urinary Bladder Neoplasms

2011
Proteomic approaches to study epigallocatechin gallate-provoked apoptosis of TSGH-8301 human urinary bladder carcinoma cells: roles of AKT and heat shock protein 27-modulated intrinsic apoptotic pathways.
    Oncology reports, 2011, Volume: 26, Issue:4

    Topics: Animals; Anticarcinogenic Agents; Apoptosis; Catechin; Cell Line, Tumor; HSP27 Heat-Shock Proteins; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Proteomics; Proto-Oncogene Proteins c-akt; Random Allocation; Urinary Bladder Neoplasms; Xenograft Model Antitumor Assays

2011
The treatment of bladder cancer in a mouse model by epigallocatechin-3-gallate-gold nanoparticles.
    Biomaterials, 2011, Volume: 32, Issue:30

    Topics: Animals; Antineoplastic Agents; Apoptosis; Catechin; Cell Line, Tumor; Gold; Immunologic Factors; Male; Mice; Nanoparticles; Tea; Urinary Bladder Neoplasms

2011
Down-regulation of glucose-regulated protein (GRP) 78 potentiates cytotoxic effect of celecoxib in human urothelial carcinoma cells.
    PloS one, 2012, Volume: 7, Issue:3

    Topics: Apoptosis; Catechin; Celecoxib; Cell Line, Tumor; Cell Survival; Cyclooxygenase 2 Inhibitors; Down-Regulation; Drug Synergism; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; G1 Phase Cell Cycle Checkpoints; Heat-Shock Proteins; Humans; Indoles; Leupeptins; Pyrazoles; RNA, Small Interfering; Stress, Physiological; Sulfonamides; Unfolded Protein Response; Urinary Bladder Neoplasms

2012
Epigallocatechin-3-gallate inhibits bladder cancer cell invasion via suppression of NF-κB‑mediated matrix metalloproteinase-9 expression.
    Molecular medicine reports, 2012, Volume: 6, Issue:5

    Topics: Anticarcinogenic Agents; Catechin; Cell Adhesion; Cell Line, Tumor; Cell Movement; Down-Regulation; Fibronectins; Humans; Matrix Metalloproteinase 9; NF-kappa B; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; RNA, Messenger; Urinary Bladder Neoplasms

2012
Preventive effects of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rat by green tea leaves.
    International journal of urology : official journal of the Japanese Urological Association, 2003, Volume: 10, Issue:3

    Topics: Animals; Anticarcinogenic Agents; Butylhydroxybutylnitrosamine; Camellia sinensis; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Phytotherapy; Plant Leaves; Plant Preparations; Rats; Rats, Wistar; Tea; Treatment Outcome; Urinary Bladder Neoplasms

2003
Inhibition of bladder tumor growth by the green tea derivative epigallocatechin-3-gallate.
    The Journal of urology, 2003, Volume: 170, Issue:3

    Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Transitional Cell; Catechin; Dose-Response Relationship, Drug; Free Radical Scavengers; Rats; Rats, Inbred F344; Tea; Tumor Cells, Cultured; Urinary Bladder Neoplasms

2003
Effect of green tea extract on the induction of ornithine decarboxylase and the activation of extracellular signal-regulated kinase in bladder carcinoma ECV304 cells.
    Nutrition and cancer, 2003, Volume: 47, Issue:1

    Topics: Apoptosis; Caspases; Catechin; Cell Survival; Enzyme Activation; Enzyme Induction; Enzyme Inhibitors; Humans; In Situ Nick-End Labeling; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Plant Extracts; Tea; Tumor Cells, Cultured; Urinary Bladder Neoplasms

2003
Growth inhibition and cell cycle arrest effects of epigallocatechin gallate in the NBT-II bladder tumour cell line.
    BJU international, 2004, Volume: 93, Issue:7

    Topics: Antineoplastic Agents, Phytogenic; Camellia sinensis; Catechin; Cell Cycle; Cell Division; Cell Line, Tumor; Drug Screening Assays, Antitumor; Flow Cytometry; Humans; Phytotherapy; Reverse Transcriptase Polymerase Chain Reaction; Urinary Bladder Neoplasms

2004
COX-2 inhibition demonstrates potent anti-proliferative effects on bladder cancer in vitro.
    The Journal of surgical research, 2004, Jun-15, Volume: 119, Issue:2

    Topics: Apoptosis; Catechin; Cell Division; Cell Line, Tumor; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Humans; In Vitro Techniques; Isoenzymes; Lactones; Membrane Proteins; Prostaglandin-Endoperoxide Synthases; Sulfones; Urinary Bladder Neoplasms

2004
(-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78.
    Cancer research, 2006, Sep-15, Volume: 66, Issue:18

    Topics: Adenosine Triphosphatases; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Breast Neoplasms; Caspase 7; Caspase Inhibitors; Catechin; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; Etoposide; Heat-Shock Proteins; Humans; Mice; Molecular Chaperones; Protein Conformation; Urinary Bladder Neoplasms

2006
A component of green tea, (-)-epigallocatechin-3-gallate, promotes apoptosis in T24 human bladder cancer cells via modulation of the PI3K/Akt pathway and Bcl-2 family proteins.
    Biochemical and biophysical research communications, 2007, Mar-23, Volume: 354, Issue:4

    Topics: Apoptosis; Catechin; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Urinary Bladder Neoplasms

2007
The green tea compound, (-)-epigallocatechin-3-gallate downregulates N-cadherin and suppresses migration of bladder carcinoma cells.
    Journal of cellular biochemistry, 2007, Oct-01, Volume: 102, Issue:2

    Topics: Animals; Anticarcinogenic Agents; Cadherins; Catechin; Catenins; Cell Line, Tumor; Cell Movement; Down-Regulation; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Mitogen-Activated Protein Kinases; Neoplasm Invasiveness; Neoplasm Transplantation; Signal Transduction; STAT3 Transcription Factor; Tea; Transplantation, Heterologous; Urinary Bladder Neoplasms

2007
Preventive effects of polyphenon E on urinary bladder and mammary cancers in rats and correlations with serum and urine levels of tea polyphenols.
    Molecular cancer therapeutics, 2007, Volume: 6, Issue:7

    Topics: Animals; Catechin; Female; Flavonoids; Mammary Neoplasms, Experimental; Phenols; Polyphenols; Rats; Rats, Inbred F344; Rats, Sprague-Dawley; Tea; Urinary Bladder Neoplasms

2007
Inhibition of urinary bladder tumors induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine in rats by green tea.
    International journal of urology : official journal of the Japanese Urological Association, 1999, Volume: 6, Issue:2

    Topics: Animals; Body Weight; Butylhydroxybutylnitrosamine; Carcinogens; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Hyperplasia; Male; Papilloma; Rats; Rats, Wistar; Tea; Urinary Bladder Neoplasms

1999